Article Information
History
- July 24, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 24, 2020 - 01:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anna Scott1,6 (ascott{at}bond.edu.au),
- Iain Chalmers2 (ichalmers{at}jameslindlibrary.org),
- Adrian Barnett3 (a.barnett{at}qut.edu.au),
- Alexandre Stephens4 (alexandre.stephens{at}health.nsw.gov.au),
- Simon E Kolstoe5 (simon.kolstoe{at}port.ac.uk),
- Justin Clark1 (jclark{at}bond.edu.au) and
- Paul Glasziou1 (pglaszio{at}bond.edu.au)
- 1 Bond University;
- 2 James Lind Library;
- 3 Queensland University of Technology;
- 4 University of Sydney;
- 5 University of Portsmouth
- ↵* Corresponding author; email: ascott{at}bond.edu.au
Posted July 24, 2020.
The ethics approval took 20 months on a trial which was meant to help terminally ill cancer patients. In the end we had to send the funding back: a survey of researchers and ethics committee members views on research ethics reviews in Australia.
